Addition of bevacizumab to paclitaxel/carboplatin in first-line management of advanced ovarian cancer: Results of the GOG 0218 phase III study

Kristin Garcia; Aarati Ranganathan; Robert L. Coleman

doi:10.3816/COC.2010.n.020

Addition of bevacizumab to paclitaxel/carboplatin in first-line management of advanced ovarian cancer: Results of the GOG 0218 phase III study

Kristin Garcia, Aarati Ranganathan, Robert L. Coleman

Gynecological Oncology & Reproductive Medicine

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	E1-E5
Journal	Clinical Ovarian Cancer
Volume	3
Issue number	2
DOIs	https://doi.org/10.3816/COC.2010.n.020
State	Published - Nov 2010

ASJC Scopus subject areas

Oncology
Obstetrics and Gynecology

Access to Document

10.3816/COC.2010.n.020

Cite this

@article{d52a7976841c4b008e220c7003da7d1b,

title = "Addition of bevacizumab to paclitaxel/carboplatin in first-line management of advanced ovarian cancer: Results of the GOG 0218 phase III study",

author = "Kristin Garcia and Aarati Ranganathan and Coleman, {Robert L.}",

year = "2010",

month = nov,

doi = "10.3816/COC.2010.n.020",

language = "English (US)",

volume = "3",

pages = "E1--E5",

journal = "Clinical Ovarian Cancer",

issn = "1941-4390",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Addition of bevacizumab to paclitaxel/carboplatin in first-line management of advanced ovarian cancer

T2 - Results of the GOG 0218 phase III study

AU - Garcia, Kristin

AU - Ranganathan, Aarati

AU - Coleman, Robert L.

PY - 2010/11

Y1 - 2010/11

UR - http://www.scopus.com/inward/record.url?scp=79951859252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951859252&partnerID=8YFLogxK

U2 - 10.3816/COC.2010.n.020

DO - 10.3816/COC.2010.n.020

M3 - Article

AN - SCOPUS:79951859252

SN - 1941-4390

VL - 3

SP - E1-E5

JO - Clinical Ovarian Cancer

JF - Clinical Ovarian Cancer

IS - 2

ER -

Addition of bevacizumab to paclitaxel/carboplatin in first-line management of advanced ovarian cancer: Results of the GOG 0218 phase III study

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this